Immunological evidence accumulation lipoprotein atherosclerotic lesion hypoascorbemic guinea pig Lipoprotein Lp atherogenic lipoprotein Lp plasma humans primates species mechanism atherogenicity understood Lp plasma several species unable ascorbate species apoprotein plasma guinea pig atherosclerosis animal dietary ascorbate depletion SDS/PAGE subsequent immunoblotting Lp atherosclerotic plaque adequate amounts ascorbate mg kg body weight day development atherosclerotic lesions animal model accumulation Lp arterial wall analogous mechanism humans similarity guinea pigs humans respect lack endogenous ascorbate production role Lp human atherosclerosis 